Intero Biosystems
Intero Biosystems41About
What does Intero Biosystems do?
Intero Biosystems is a biotechnology startup that creates advanced adult human stem cell-derived intestinal organoid platforms for drug discovery and development. Their flagship product, GastroScreen, is a 'mini-gut in a dish' that accurately mimics the human intestine, including key cell types, functional smooth muscle, blood vessels, and neurons. This technology enables comprehensive safety and efficacy testing, providing a more predictive and human-relevant model for preclinical drug developm…
Is Intero Biosystems trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Intero Biosystems is 52 out of 100, based on site security posture and privacy practices.
What is Intero Biosystems's valuation?
StartupHub estimates Intero Biosystems's effective valuation at $7.6M (range $5.0M to $12.0M, 17% confidence), based on comparable companies in the sector.
How much funding has Intero Biosystems raised?
Intero Biosystems has raised a total of $2M in funding. The most recent round on record is Pre-Seed.
Where is Intero Biosystems headquartered?
Intero Biosystems is headquartered in Ann Arbor, United States.
When was Intero Biosystems founded?
Intero Biosystems was founded in 2024.
What industry does Intero Biosystems operate in?
Intero Biosystems operates in Biotech & Health, Biotechnology and pharmaceuticals, Biotech, Drug Discovery, Organoid Intelligence, Genomics.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 3 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.